期刊文献+

氟伐他汀及氯沙坦对血管紧张素Ⅱ诱导人足细胞VEGF表达的影响 被引量:3

Effects of fluvastatin and losartan on vascular endothelial growth factor biosynthesis in human podocyte treated by angiotensin Ⅱ
下载PDF
导出
摘要 目的:观察氟伐他汀及氯沙坦对血管紧张素Ⅱ(angiotensinⅡ,AngⅡ)刺激人足细胞血管内皮细胞生长因子(vascu-lar endothelial growth factor,VEGF)表达的影响。方法:采用不同浓度的(10-9~10-5 mol/L)AngⅡ刺激人足细胞24 h以确定最适干预浓度;选择最适干预浓度(10-7 mol/L)的AngⅡ刺激0、6、12、24 h以确定最适干预时间;AngⅡ(10-7 mol/L)和不同浓度的(10-7~10-5 mol/L)氟伐他汀共同干预足细胞24 h以确定氟伐他汀最适干预浓度;AngⅡ(10-7 mol/L)和不同浓度的(10-6~10-4mol/L)氯沙坦共同干预足细胞24 h以确定氯沙坦最适干预浓度;氟伐他汀和氯沙坦(均为10-6 mol/L)共同干预足细胞24 h。Western blot检测人足细胞VEGF的表达。结果:①10-7 mol/L AngⅡ刺激人足细胞24 h后表达VEGF增加最明显;②氟伐他汀干预组与AngⅡ刺激组比较,VEGF表达明显下降,浓度10-5 mol/L下降最明显。氯沙坦干预组与AngⅡ刺激组比较,VEGF表达明显下降,浓度10-4 mol/L下降最明显;③10-6 mol/L氟伐他汀和10-6 mol/L氯沙坦共同干预人足细胞后,VEGF表达下降比氟伐他汀、氯沙坦单药干预组更明显(P<0.01)。结论:AngⅡ促进人足细胞表达VEGF,具有一定的时间和浓度依赖性,氟伐他汀和氯沙坦均可抑制此作用,且二者具有协同抑制效应。 Objective:To investigate the effects of fluvastatin and losartan on vascular endothelial growth factor(VEGF) biosynthesis by human podocyte treated with angiotensin Ⅱ(AngⅡ).Methods:Cultured human podocytes were incubated with AngⅡ for 24 h at the concentration from 10-9 to 10-5 mol / L to choose the suitable concentration,and the optimal treatment time were chosed at the AngⅡ concentration of 10-7 mol / L after treated different times(0,6,12 and 24 hours).The podocytes were incubated with Ang Ⅱ(10-7 mol / L) and different concentrations of fluvastatin(10-7 ~10-5 mol / L) for 24 h to choose the suitable concentration of fluvastatin.Then the podocytes were incubated with AngⅡ(10-7 mol / L) and different concentrations of losartan(10-6 ~10-4 mol / L) for 24 h to choose the suitable concentration of losartan.Finally,the podocytes were incubated by AngⅡ(10-7 mol / L) with fluvastatin and losartan(both 10-6 mol / L),and VEGF expression was detected using Western bolt.Results: ① VEGF synthesis by human podocyte cultured in Ang Ⅱ medium increased obviously at the concentration of 10-7 mol / L after 24 h.② Fluvastatin or losartan inhibited VEGF expression stimulated by Ang Ⅱ,and the 10-5 mol / L of fluvastatin and the 10-4 mol / L of losartan had the most siginificant effect.③Fluvastatin(10-6 mol / L) combined with losartan(10-6 mol / L) inhibited VEGF expression more siginificantly than the effect of each alone.Conclusion:It is suggested that Ang Ⅱ stimulates VEGF biosynthesis by human podocyte in a time and concentration pattern.Both fluvastatin and losartan can inhibit this effect,and they have synergistic inhibitory effects.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2011年第8期1123-1127,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省卫生厅科研基金资助(H200317)
关键词 血管紧张素II 足细胞 氟伐他汀 氯沙坦 血管内皮细胞生长因子 Angiotensin II podocyte fluvastatin losartan vascular endothelial growth factor
  • 相关文献

参考文献24

  • 1Kikkawa R, Koya D, Haneda M. Progression of diabetic nephropathy[J]. Am J Kidney Dis,2003,41 (Suppl 1): S19-S21.
  • 2Ritz E, Rychlick I, Locatelli F, et al. End-stage renal failure in type 2 diabetes:a medical catastrophe of world-wide dimensions [J]. Am J Kidney Dis,1999,34 (5): 795-808.
  • 3Cha DR,Kang YS,Han SY,et al. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats [J]. Endocrinol, 2004,183(1) : 183-194.
  • 4Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS. Amelioration of long-term renal changes in obese type 2 diabetes mice by a neutralizing vascular endothelial growth factor antibody[J]. Diabetes, 2002,51 (10) :3090-3094.
  • 5Sun Hee,Sung Fuad N Ziyadeh, Amy Wang, et al. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice [J]. Am Soc Nephrol, 2006,17( 11 ) : 3093-3104.
  • 6QP Li,RZ Shi,JCh Wang,et al. Angiotensin II induces vascular endothelial growth factor synthesis in mesenchymal stem cells [ J ]. Experimental cell research, 2009,315 (1):10-15.
  • 7Denis Feliers,Balakuntalam S Kasinath. Mechanism of VEGF expression by high glucose in proximal tubule epithelial cells [J]. Molecular and Cellular Endocrinology, 2010,314(1) : 136-142.
  • 8Kang YS,Park YG,Kim BK,et al. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes [J]. Mol Endocrinol, 2006,36(2) : 377-388.
  • 9覃志成,齐悦,李荣山,黄轶嵘,邵珊,白波.氯沙坦对血管紧张素Ⅱ诱导人足细胞分泌VEGF的影响[J].中国中西医结合肾病杂志,2009,10(5):423-425. 被引量:7
  • 10Wolf G,Chen S,Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy[J]. Diabetes, 2005,54 (6) : 1626-1634.

二级参考文献10

  • 1Shulman K, Re,sen S, Tognazzi K, et al. Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular disuses. J Am Soc Nephrol, 1996,7(5):661 - 666.
  • 2Izzedine H, Rixe O, Billemont B, et al. Angiogenesis inhibitor therapies: focus on kidney toxicity and hypertension. Am J Kidney Dis, 2007,50 (2) : 203 - 218.
  • 3Davis B, Dei CA, Long DA, et al. Podocyte - specific expression of angiopoietin - 2 causes proteinuria and apoptosis of glomerular endothelia. J Am Soc Nephrol,2007,18(8) :2320 - 2329.
  • 4Bailey E, Bottomley MJ, Westwell S, et al. Vascular endothelial growth factor mRNA expression in minimal change membranous and diabetic nephropathy demonstrated by non - isotopic in situ hybridisation. J Clin Pathol, 1999,52(10) : 735 - 738.
  • 5Kim NH,Oh JH,Seo JA,et al. Vascular endothelial growth factor(VEGF) and soluble VEGF receptor FLT- 1 in diabetic nephropathy. Kidney Int, 2005,67( 1 ) : 167 - 177.
  • 6Hoffmann S, Podlich D, Hahnel B, et al. Angiotensin Ⅱ type Ⅰ receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol, 2004,15 : 1475 - 1487.
  • 7Young SK, Yun GP, Bo KK, et al. Angiotensin Ⅱ stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. J Mol Endocrinol, 2006,36 (2):377 - 388.
  • 8王永铭.临床药理学.第2版.上海:上海医科大学出版社,2001.75.
  • 9杨爱成,贾汝汉.血管内皮生长因子与肾脏病研究进展[J].临床肾脏病杂志,2002,2(2):87-89. 被引量:1
  • 10刘春蓓,胡伟新.血管内皮生长因子在肾纤维化中的作用[J].肾脏病与透析肾移植杂志,2004,13(2):172-176. 被引量:2

共引文献10

同被引文献33

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部